Supercharge Your Innovation With Domain-Expert AI Agents!

Zedoary injection preparation and its preparing method

The technology of injection preparation and Curcuma curcuma, applied in the field of Curcuma curcuma injection preparation and preparation thereof, can solve the problems of waste of traditional Chinese medicine resources, low release rate of fat-soluble drugs, insoluble in water, etc.

Inactive Publication Date: 2007-01-24
福州凯瑞医药咨询有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the encapsulation rate of β-CD to fat-soluble drugs is only about 60%, because it is particularly difficult to extract fat-soluble drugs in traditional Chinese medicine. , which is a huge waste of traditional Chinese medicine resources and reduces the pharmacological efficacy of traditional Chinese medicine preparations; the inclusion rate has not been well resolved in the current preparation process, and the release rate of fat-soluble drugs included by β-CD is low, resulting in The concentration of fat-soluble drugs is low, and the pharmacological effects cannot be fully exerted
[0004] Curcuma aerugionosa Roxb is the rhizome of Curcuma aerugionosa Roxb., which has the functions of promoting qi, breaking blood, eliminating stagnation and relieving pain. Modern pharmacological research shows that the effective parts extracted from Curcuma have anti-cancer, anti-virus, pain relief, antipruritic, etc. Function, injections, suppositories, and ointments made from the effective parts of Zedoary have been widely used in clinics; the effective parts of Zedoary are fat-soluble components, which are difficult to dissolve in water. The marketed Zedoary injection preparations mainly use some surfactants to help dissolve Such as Tween, etc., but these co-solvents have hemolytic side effects, which have great limitations in clinical application and are potentially dangerous to patients; the patent application number is 02109680, which uses stirring method or grinding method or ultrasonic oscillation Method, use hydroxypropyl-β-cyclodextrin to carry out inclusion to the effective part of Curcuma, the patent mentions that the inclusion rate is under the same inclusion conditions, only the amount of hydroxypropyl-β-cyclodextrin is different, so that The inclusion rate of hydroxypropyl-β-cyclodextrin spans from 62% to 95%, its reliability is questionable, and the patent does not do any experiments and elaborations on the inclusion rate of hydroxypropyl-β-cyclodextrin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Mice S 180 tumor growth inhibitory effect

[0034] Experimental animals: healthy mice, weighing 16-20g, half male and half male. (Provided by Beijing University of Traditional Chinese Medicine) Tumor strain: mouse S 180 (Provided by Beijing University of Traditional Chinese Medicine)

[0035] Experimental drug: normal saline (provided by the laboratory of Beijing Qianluchun Technology Co., Ltd.)

[0036] Zedoary Oil Injection (provided by Heilongjiang Qingan Pharmaceutical Co., Ltd.)

[0037] Curcuma injection prepared according to the patent application number 02109680 (provided by the laboratory of Beijing Ganluchun Technology Co., Ltd.)

[0038] Curcuma injection preparation of the present invention (provided by the laboratory of Beijing Ganluchun Science and Technology Co., Ltd.)

[0039] Experimental method: Take the inoculated passage mouse S 180 , add saline to the homogenizer to make mouse S 180 Tumor homogenate was diluted with normal saline 1:...

Embodiment 2

[0043] Experiment of antiviral effect by semi-in vivo method

[0044] Experimental drug: normal saline (provided by the laboratory of Beijing Qianluchun Technology Co., Ltd.)

[0045] Zedoary Oil Injection (provided by Heilongjiang Qingan Pharmaceutical Co., Ltd.)

[0046] Curcuma injection prepared according to the patent application number 02109680 (provided by the laboratory of Beijing Ganluchun Technology Co., Ltd.)

[0047] Curcuma injection preparation of the present invention (provided by the laboratory of Beijing Ganluchun Science and Technology Co., Ltd.)

[0048] Experimental method: The experiment adopts the semi-in vivo method, the normal control group and the virus control group, the drugs of different concentrations are respectively directly reacted with the virus, and immediately inoculated into the allantoic cavity of the chicken embryo, the inoculation hole is sealed with paraffin, and cultured in a 37°C incubator After 48 hours, the urine of each embryo was c...

Embodiment 3

[0071] (1) Get Curcuma, pulverize it, put it into a volatile oil extractor, extract the volatile oil completely, and use the volatile oil for subsequent use; the residue after extracting the volatile oil is extracted twice with 80% ethanol in 6 times the amount, the first time is 2 hours, the second time is 1 hour, Filtrate, combine the extracts, recover the ethanol from the filtrate under reduced pressure, and concentrate to an extract with a relative density of about 1.15 (50°C), extract the extract with an equal amount of ethyl acetate for 6 times, combine the ethyl acetate extracts, and recover under reduced pressure Ethyl acetate was used up, concentrated and dried for later use;

[0072] (2) Get zedoary volatile oil and ethanol extract, add ethanol to dissolve completely, simultaneously according to the ratio of zedoary volatile oil and ethanol extract: 2-hydroxypropyl β-cyclodextrin=1: 30, 2-hydroxypropyl β- Make a saturated solution of cyclodextrin with distilled water...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention features that effective component of zedoary is clathrated with 2-hydroxypropyl beta-cyclodextrin in the clathrated rate over 90 % and then mixed with medicine supplementary material, and the mixture is then prepared into water injection, transfusion preparation, powder for injection or freeze dried powder for injection. Pharmacological experiment shows that the zedoary injection preparation of the present invention has high pharmacological effect.

Description

Technical field [0001] The invention belongs to the technical field of traditional Chinese medicine pharmacy, and in particular relates to a curcuma injection preparation and a preparation method thereof. Background technique [0002] 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD for short) is a kind of hydroxyalkylated derivatives of β-cyclodextrin. In each glucose residue of β-cyclodextrin (β-CD), the hydrogen atoms of 3 hydroxyl groups in C-2, C-3 and C-6 can be replaced by hydroxypropyl (-CHCHOHCH) to generate 2-HP-β-CD, 3-HP-β-CD, 2,3-DHP-β-CD, 2,6-DHP-β-CD, 2,3,6-THP-β-CD and other homologs . If the conditions are controlled, the product mainly composed of 2-HP-β-CD can also be generated. 2-HP-β-CD is currently the CD derivative with the most research, the most sufficient work, the most comprehensive safety data collected, and the best effect on drug solubilization and stability improvement. Many properties of 2-HP-β-CD have changed, mainly in the following aspects: (1) ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/906A61K9/08A61K9/19A61K9/14A61K47/40A61P29/02A61P31/12A61P35/00A61K125/00
Inventor 张正生
Owner 福州凯瑞医药咨询有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More